Hutch News
Results per Page:
A liquid asset: Lung cancer tumor profiling from bronchoalveolar lavage fluid
From Dr. Viswam Nair, Clinical Research Division
Interactions between oncologists and patients – The lung cancer experience
From Dr. Casey Walsh, Fred Hutch Clinical Research Division, Dr. Morhaf Al Achkar, University of Washington, and colleagues
The impact of COVID-19 on pediatric hematopoietic stem cell transplant recipients
From Dr. Neel Bhatt, Clinical Research Division, and the Center for International Blood and Marrow Transplant Research
Navigating a new faculty position and the COVID-19 pandemic
From the Termini Lab, Clinical Research Division
Outcome predictions for patients with graft-versus-host disease
From the Hematopoietic Cell Transplantation Program, Clinical Research Division
The long-term impact of neurocognitive impairment after transplant
From the Chow Group, Clinical Research Division
No immature cells allowed – removing naïve T-cells in hematopoietic stem cell transplants
From the Bleakley Lab, Clinical Research Division
Breaking down barriers: Language and survival outcomes after transplant
From the Lee Lab, Clinical Research Division
Overcoming exhaustion: Engineered T-cells and pancreas cancer
From the Greenberg Lab, Clinical Research Division, Fred Hutch and the Stromnes Lab, University of Minnesota
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
Translocation tracker: digital droplet PCR in chronic myelogenous leukemia
From the Radich Lab, Clinical Research Division
Calculating the risk: Lower respiratory tract infection in transplant recipients
From the Boeckh Lab, Clinical Research and Vaccine and Infectious Disease Divisions
Does location matter? Cancer and COVID-19
From Dr Hawley, Clinical Research Division, and the COVID-19 and Cancer Consortium
Leading the way: BLEAT, a novel HLA-B Leader Assessment Tool
From the Petersdorf Lab, Clinical Research Division
Potential strategies for mitigating CD19 CAR T-cell associated toxicities
From the Gauthier Group, Clinical Research Division
Conditioning treatment regimens for hematopoietic stem cell transplantation
From the Deeg Group, Clinical Research Division
Best practices for cancer survivorship care in young adults
From Drs Syrjala and Baker, Clinical Research Division
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Repairing the damage: regeneration of the mouse thymus
From the Dudakov Lab, Clinical Research Division
Thwarting relapse in patients with acute myeloid leukemia
From the Hill Lab, Clinical Research Division